Clinical Trial Update: A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140) [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 trial evaluating an investigational drug for benign prostatic hyperplasia (NCT00127179).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Investigational Study Drug

Snippet

Sponsor: Organon and Co | Conditions: Benign Prostatic Hyperplasia | Phase 3 | Status: COMPLETED